EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effect of ADAMTS13 on graft‐versus‐host disease

Dan Li, Min Soon Cho iD, Ricardo Gonzalez-Delgado iD, Xiaowen Liang, Jing-Fei Dong, Miguel A Cruz, Qing Ma, Vahid Afshar-Kharghan iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Dan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Graft vs Host Disease, ADAMTS13 Protein, Mice, Inbred BALB C, T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, ASH Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) can potentially cure malignant blood disorders and benign conditions such as haemoglobinopathies and immunologic diseases. However, allo‐HSCT is associated with significant complications. The most common and debilitating among them is graft‐versus‐host disease (GVHD). In GVHD, donor‐derived T cells mount an alloimmune response against the recipient. The alloimmune response involves several steps, including recognition of recipient antigens, activation and proliferation of T cells in secondary lymphoid organs, and homing into GVHD‐targeted organs. Adhesion molecules on T cells and endothelial cells mediate homing of T cells into lymphoid and non‐lymphoid tissues. In this study, we showed that Von Willebrand factor (VWF), an adhesion molecule secreted by activated endothelial cells, plays an important role in mouse models of GVHD. We investigated the effect of the VWF‐cleaving protease ADAMTS13 on GVHD. We found that ADAMTS13 reduced the severity of GVHD after bone marrow transplantation from C57BL6 donor to BALB/C recipient mice. A recombinant VWF‐A2 domain peptide also reduced GVHD in mice. We showed that ADAMTS13 and recombinant VWF‐A2 reduced the binding of T cells to endothelial cells and VWF in vitro, and reduced the number of T cells in lymph nodes, Peyer's patches and GVHD‐targeted organs in vivo. We identified LFA‐1 (αLβ2) as the binding site of VWF on T cells. Our results showed that blocking T‐cell homing by ADAMTS13 or VWF‐A2 peptide reduced the severity of the GVHD after allo‐HSCT, a potentially novel method for treating and preventing GVHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseADAMTS13 ProteinMice, Inbred BALB CT-LymphocytesMice, Inbred C57BLvon Willebrand FactorAnimalsMiceHumansTransplantation, HomologousHematopoietic Stem Cell TransplantationDisease Models, AnimalBone Marrow TransplantationEndothelial Cells

Stichwörter der Autor:innen

ADAMTS13Von Willebrand factorgraft‐versus‐host disease

Substanzen

ADAMTS13 Proteinvon Willebrand Factor

Autor:innen und Institutionen

  • Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center, Houston, Texas, USA.
  • Bloodworks Research Institute and Hematology Division, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey VA Medical Center, Houston, Texas, USA.
  • Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Min Soon Cho, Ricardo Gonzalez-Delgado, Vahid Afshar-Kharghan

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • ASH Foundation
  • NHLBI NIH HHS
  • Ovarian Cancer Research Alliance
  • National Institute of General Medical Sciences
  • National Heart, Lung, and Blood Institute
  • National Cancer Institute

Zitieren

APA

Li, D., Cho, M. S., Gonzalez-Delgado, R., Liang, X., Dong, J. F., Cruz, M. A., Ma, Q., & Afshar-Kharghan, V. (2024). The effect of ADAMTS13 on graft‐versus‐host disease. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18457

Vancouver

Li D, Cho MS, Gonzalez-Delgado R, Liang X, Dong JF, Cruz MA, et al. The effect of ADAMTS13 on graft‐versus‐host disease. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18457

BibTeX
@article{Li2024,
  author = {Li, Dan and Cho, Min Soon and Gonzalez-Delgado, Ricardo and Liang, Xiaowen and Dong, Jing-Fei and Cruz, Miguel A and Ma, Qing and Afshar-Kharghan, Vahid},
  title = {The effect of ADAMTS13 on graft‐versus‐host disease},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18457}
}
Kostenlos starten →